PTIXW Protagenic Therapeutics, Inc.\new

Fundamentals / CIK 0001022899 / USD
Other share classes on CIK 0001022899: PTIX

Protagenic Therapeutics, Inc.\new reported $0 in revenue and net income of $5.66M for the fiscal year ended March 31, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PTIXW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$1.93M$966K$0-$5.28MFY 2017 Net Income: -$2.26M2017FY 2018 Net Income: -$2.56M2018FY 2019 Net Income: -$1.75M2019FY 2020 Revenue: $0FY 2020 Net Income: -$2.55M2020FY 2021 Revenue: $0FY 2021 Net Income: -$4.52M2021FY 2022 Revenue: $0FY 2022 Net Income: -$3.56M2022FY 2023 Revenue: $0FY 2023 Net Income: -$5.00M2023FY 2024 Revenue: $0FY 2024 Net Income: -$5.53M2024FY 2025 Revenue: $0FY 2025 Net Income: -$3.59M2025FY 2026 Revenue: $0FY 2026 Net Income: $1.37M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $0 $0 $0 $0 $0 -- -- --
Research & Development $902K $377K $3.84M $3.06M $1.59M $1.14M $700K $808K $881K $717K
Total Operating Expenses $4.50M $2.59M $5.70M $4.53M $3.56M $4.14M $2.55M $2.09M $2.31M $2.37M
Operating Income -$4.50M -$2.59M -$5.70M -$4.53M -$3.56M -$4.14M -$2.55M -$2.09M -$2.31M -$2.37M
EBITDA -$4.45M -- -$5.65M -$4.50M -$3.56M -- -$2.55M -$2.09M -$2.31M -$2.37M
Interest Income -- -- $43K $264K $186K $33K $502 -- -- --
Interest Expense -- -- -- $108K $137K $497K $246K -- -- --
Income Before Tax $1.37M -$3.59M -$5.53M -$5.00M -$3.56M -$4.52M -$2.55M -$1.75M -$2.56M -$2.26M
Net Income $1.37M -$3.59M -$5.53M -$5.00M -$3.56M -$4.52M -$2.55M -$1.75M -$2.56M -$2.26M
Basic EPS $0.59 -$0.67 -$15.83 -$16.11 -$11.48 -$69.47 -$14.01 -$9.52 -$14.01 -$12.32
Diluted EPS $0.59 -$0.67 -$15.83 -$16.11 -$11.48 -$17.37 -$14.01 -$9.52 -$14.01 -$12.32
Basic Shares Outstanding 2.3M 5.4M 349.9K 310.2K 308.3K 65.8K 184.6K 183.2K 183.2K 183.2K
Diluted Shares Outstanding 2.3M 5.4M 349.9K 310.2K 308.3K 263.1K 184.6K 183.2K 183.2K 183.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- $0 $0
Research & Development $27K $110K $81K $154K $218K $394K $880K $135K
Total Operating Expenses $671K $961K $120K $925K $1.11M $1.21M $1.45M $401K
Operating Income -$671K -$961K -$120K -$925K -$1.11M -$1.21M -$1.45M -$401K
EBITDA -$668K -$953K -$109K -$913K -$1.10M -$1.20M -$1.44M -$401K
Interest Income -- -- -- -- -- -- $8.1K $9.0K
Income Before Tax -$667K -$964K $5.08M $2.21M -$869K -$5.06M -$1.44M -$850K
Net Income -$667K -$964K $5.08M $2.21M -$869K -$5.06M -$1.44M -$850K
Basic EPS -$0.37 -$0.53 -- $1.14 -$0.47 -$1.37 -$2.75 -$0.16
Diluted EPS -$0.37 -$0.53 -- $1.14 -$0.47 -$1.37 -$2.75 -$0.16
Basic Shares Outstanding 1.8M 1.8M -- 1.9M 1.8M 3.7M 523.2K 5.4M
Diluted Shares Outstanding 1.8M 1.8M -- 1.9M 1.8M 3.7M 523.2K 5.4M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.51M $15K $1.84M $1.29M $215K $541K $671K $799K $362K $400K
Short-Term Investments -- -- -- $2.77M $7.76M $9.83M -- -- -- --
Cash & Short-Term Investments $1.51M $15K $1.84M $4.06M $7.98M $10.37M $671K $799K $362K $400K
Inventory -- $1.0K -- -- -- -- -- -- -- --
Total Current Assets $1.54M $89K $1.88M $4.20M $8.04M $11.06M $879K $842K $696K $1.78M
Property, Plant & Equipment, Net $15K $60K $73K $123K $1.8K -- -- $296 $611 $1.0K
Intangible Assets $2.09M -- -- -- -- -- -- -- -- --
Total Non-Current Assets $2.11M $0 $73K $123K $1.8K $0 $0 $296 $611 $1.0K
Total Assets $3.65M $89K $1.96M $4.32M $8.04M $11.06M $879K $842K $697K $1.78M
Accounts Payable $950K $961K -- -- -- -- -- -- -- --
Other Current Liabilities $0 $779K -- -- -- -- -- -- -- --
Total Current Liabilities $1.03M $5.04M $943K $655K $1.12M $800K $655K $1.20M $908K $562K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $318K $1.37M $279K $0 $0
Total Liabilities $1.03M $5.04M $943K $655K $1.12M $1.12M $2.03M $1.48M $908K $562K
Common Stock $182 $54 $52 $444 $434 $432 $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$4.03M -$5.40M -$36.30M -$30.78M -$25.78M -$22.22M -$17.70M -$15.15M -$13.40M -$10.84M
Accumulated Other Comp. Income -- -$130K -$130K -$114K -$677K -$248K -$172K -$172K -$171K -$168K
Total Stockholders' Equity $2.62M -$4.95M -$3.32M $3.67M $6.92M $9.94M -$1.15M -$634K -$211K $1.22M
Total Equity $2.62M -$4.95M -$3.32M $3.67M $6.92M $9.94M -$1.15M -$634K -$211K $1.22M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $77K $566K $1.51M $2.21M $2.72M $15K $1.84M $1.06M
Cash & Short-Term Investments $77K $566K $1.51M $2.21M $2.72M $15K $1.84M $1.06M
Inventory -- -- -- $1.1K $1.1K $1.0K -- --
Total Current Assets $188K $710K $1.54M $2.30M $2.86M $89K $1.88M $1.42M
Property, Plant & Equipment, Net $3.3K $6.2K $15K $39K $51K $60K $73K $86K
Intangible Assets $2.08M $2.08M $2.09M $2.09M $2.09M -- -- --
Total Non-Current Assets $2.08M $2.09M $2.11M $2.13M $2.14M $0 $73K $86K
Total Assets $2.27M $2.80M $3.65M $4.43M $5.00M $89K $1.96M $1.51M
Accounts Payable $1.07M $1000K $950K $2.03M $1.64M $961K -- --
Other Current Liabilities -- -- $0 $840K $842K $779K -- --
Total Current Liabilities $1.15M $1.07M $1.03M $6.82M $9.70M $5.04M $943K $789K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $1.15M $1.07M $1.03M $6.82M $9.70M $5.04M $943K $789K
Common Stock $182 $182 $182 $195 $195 $54 $52 $481
Retained Earnings -$5.66M -$4.99M -$4.03M -$9.11M -$11.32M -$5.40M -$36.30M -$34.75M
Accumulated Other Comp. Income -- -- -- -- -- -$130K -$130K -$130K
Total Stockholders' Equity $1.12M $1.72M $2.62M -$2.39M -$4.70M -$4.95M -$3.32M -$2.47M
Total Equity $1.12M $1.72M $2.62M -$2.39M -$4.70M -$4.95M -$3.32M -$2.47M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $1.37M -$3.59M -$5.53M -$5.00M -$3.56M -$4.52M -$2.55M -$1.75M -$2.56M -$2.26M
Depreciation & Amortization $49K -- $50K $28K $30 -- $286 $339 $347 $148
Stock-Based Compensation $419K -- $923K $667K $865K $1.52M $1.65M $798K $1.13M $888K
Change in Inventory -$26 -$29 -- -- -- -- -- -- -- --
Change in Payables $1.04M $182K -- -- -- -- -- -- -- --
Operating Cash Flow -$2.81M -$1.77M -$4.22M -$3.70M -$1.99M -$2.80M -$1.35M -$488K -$1.07M -$1.38M
Capital Expenditure -$3.3K -- -- -$150K -$1.8K -- -- -- -- --
Free Cash Flow -$2.81M -- -- -$3.85M -$2.00M -- -- -- -- --
Purchases of Investments -- -- -$297K -$2.76M -$34K -$10.40M -- -- -- --
Investing Cash Flow $630K -- $2.80M $4.78M $1.60M -$9.91M -- $250K $1.05M -$1.29M
Common Stock Issued $395K $200 -- -- -- -- -- -- -- --
Financing Cash Flow $3.87M $1.81M $1.96M -- -- $12.58M $1.22M $670K -- --
Net Change in Cash $1.70M $40K $551K $1.07M -$326K -$130K -$128K $436K -$37K -$2.70M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$667K -$964K $5.08M $2.21M -$869K -$5.06M -$1.44M -$850K
Depreciation & Amortization $2.9K $8.3K $12K $13K $13K $13K $13K $0
Stock-Based Compensation $62K $67K $92K $96K $106K $125K $236K $245K
Change in Inventory -- -- $10 $1 $20 -$57 -- --
Change in Payables $69K $50K $827K $389K -$442K $265K -- --
Operating Cash Flow -$489K -$944K $266K $74K -$1.40M -$1.75M -$1.07M -$820K
Purchases of Investments -- -- -- -- -- -- -- $0
Investing Cash Flow -- -- -$313K $0 $0 $943K -- $0
Common Stock Issued -- -- $0 $0 $0 $395K -- --
Financing Cash Flow -- -- -$534K -$584K -$15K $5.01M $103K --
Net Change in Cash -$489K -$944K -$582K -$510K -$1.41M $4.20M -$966K $783K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) 52.2% -- -- -136.3% -51.4% -45.5% -- -- -- -185.3%
Return on Assets (ROA) 37.5% -4031.6% -282.5% -115.7% -44.2% -40.9% -289.9% -207.9% -367.0% -126.9%
Current Ratio 1.50x 0.02x 2.00x 6.41x 7.18x 13.83x 1.34x 0.70x 0.77x 3.17x
Quick Ratio 1.46x 0.02x 1.95x 6.19x 7.12x 12.97x 1.02x 0.67x 0.40x 0.71x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 506.4% 316.9% 52.2% -- -- -- -- --
Return on Assets (ROA) 249.3% 195.3% 37.5% -116.4% -164.3% -- -3588.4% -178.0%
Current Ratio 0.16x 0.66x 1.50x 0.34x 0.29x -- 0.02x 2.00x
Quick Ratio 0.07x 0.53x 1.46x 0.34x 0.29x -- 0.02x 1.95x
Source: SEC EDGAR CompanyFacts (CIK 0001022899) · from September 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal